Skip to main content
. 2021 Mar 18;264:81–89. doi: 10.1016/j.jss.2021.03.017

Table 2.

Outcomes of COVID-19 patients.

Total (N = 39) IMV-alone (N = 21) RVAD/ECMO (N = 18) P value
In hospital mortality 13 (33.3%) 11 (52.4%) 2 (11.1%) 0.008
30-d Mortality 10 (25.6%) 9 (42.9%) 1 (5.6%) 0.011
ICU LOS (d) 13 (6-27)
(N = 37)
11.5 (6-22.5)
(N = 20)
21 (9-36)
(N = 17)
0.067
Postintubation ICU days 12 (6-27)
(N = 37)
8.5 (5.5-22.5)
(N = 20)
16 (9-27)
(N = 17)
0.17
Hospital LOS (d) 18 (9-36) 14 (8-29) 25.5 (17-39) 0.054
Postintubation hospital days 16 (8-32) 9 (6-27) 20 (11-40) 0.14
Duration of mechanical ventilation (d) 7.5 (1-22)
(N = 26)
10 (5-20)
(N = 10)
5 (1-34)
(N = 16)
0.44
Acute kidney injury 15 (38.5%) 15 (71.4%) 0 (0%) <0.001
Tracheostomy 10 (27.0%)
(N = 37)
3 (14.3%)
(N = 21)
7 (43.8%)
(N = 16)
0.067

ICU = intensive care unit; IMV = invasive mechanical ventilation; LOS = length of stay; RVAD/ECMO = right ventricular assist device/extracorporeal membrane oxygenation.

Bold text indicates p-value is significant (i.e. p<0.05).